Myriad Genetics (MYGN) Tops Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $6.18 -0.16%
EPS Growth %: -220.0%
Financial Fact:
Interest income: 300K
Today's EPS Names:
UBAB, LOAN, FITB, More
EPS Growth %: -220.0%
Financial Fact:
Interest income: 300K
Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.06), $0.08 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $173.1 million versus the consensus estimate of $156.2 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
- VIST Financial Corp. (VIST) Misses Q2 EPS by 76c
- JPMorgan upgrades 3M, Emerson Electric to Overweight ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
